Stockscreener 앱 받기
107.19
1.20%
-1.30
시간 외 거래:
107.01
-0.18
-0.17%
전일 마감가:
$108.49
열려 있는:
$108.73
하루 거래량:
10.42M
Relative Volume:
1.11
시가총액:
$186.26B
수익:
$44.33B
순이익/손실:
$6.50B
주가수익비율:
28.84
EPS:
3.717
순현금흐름:
$7.40B
1주 성능:
-0.88%
1개월 성능:
-4.46%
6개월 성능:
-21.21%
1년 성능:
-15.88%
1일 변동 폭
$107.14
$109.77
1주일 범위
$107.14
$111.86
52주 변동 폭
$105.27
$139.06
애보트 래버러토리스 Stock (ABT) Company Profile
명칭
Abbott Laboratories
전화
(224) 667-6100
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Compare ABT vs SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-10 | 개시 | The Benchmark Company | Buy |
| 2025-07-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-06-16 | 개시 | Leerink Partners | Market Perform |
| 2024-10-08 | 개시 | Oppenheimer | Outperform |
| 2024-09-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-21 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 재확인 | Barclays | Overweight |
| 2023-04-20 | 재확인 | Bernstein | Outperform |
| 2023-04-20 | 재확인 | JP Morgan | Overweight |
| 2023-04-20 | 재확인 | Raymond James | Outperform |
| 2023-04-20 | 재확인 | UBS | Buy |
| 2023-04-20 | 재확인 | Wolfe Research | Underperform |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-10-26 | 개시 | Mizuho | Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-27 | 재확인 | Credit Suisse | Outperform |
| 2022-01-27 | 재확인 | Morgan Stanley | Overweight |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | UBS | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-27 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-01-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-06-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-02-07 | 재확인 | BofA/Merrill | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-11-30 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-01-30 | 재확인 | Citigroup | Neutral |
| 2018-01-25 | 재확인 | Stifel | Buy |
| 2018-01-25 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-19 | 재확인 | Stifel | Buy |
모두보기
애보트 래버러토리스 주식(ABT)의 최신 뉴스
Abbott Labs Q4 2025: Revenue Miss, Device Growth & Exact Sciences AcquisitionNews and Statistics - IndexBox
1 magnificent dividend stock down 22% that's a screaming buy right now - MSN
1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now - The Motley Fool
1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now - The Motley Fool
AIA Group Ltd Raises Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (ABT) likely to benefit from nutrition segment recovery - MSN
Abbott Investors Ink $40M Deal Over Infant Formula Crisis - Law360
Futures Contracts for Abbott Laboratories Futures - TradingView
Selling pressure pushes Abbott Laboratories stock lower in today's trading - Traders Union
Abbott Labs Leaders, Shareholders Reach Formula Suit Settlement - Bloomberg Law News
Is Trending Stock Abbott Laboratories (ABT) a Buy Now? - Yahoo Finance
Abbott’s $21 Billion Exact Sciences Acquisition Supports a $179 Price Target - TIKR.com
Wilmington Savings Fund Society FSB Sells 25,557 Shares of Abbott Laboratories $ABT - MarketBeat
Danske Bank A S Takes $116.41 Million Position in Abbott Laboratories $ABT - MarketBeat
Coldstream Capital Management Inc. Increases Holdings in Abbott Laboratories $ABT - MarketBeat
Will New Diabetes and Cardio Data Shift Abbott Laboratories' (ABT) Chronic-Disease Innovation Narrative - simplywall.st
Abbott Laboratories Stock (ISIN: US0028241000) Hits Multi-Month Lows Amid Pullback: Buy the Dip Oppo - AD HOC NEWS
Abbott Laboratories $ABT Shares Purchased by Mariner LLC - MarketBeat
Mairs & Power Inc. Decreases Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Stock (ISIN: US0028241000) Shows Resilience Amid Healthcare Sector Headwinds, Tr - AD HOC NEWS
Mercer Global Advisors Inc. ADV Buys 79,707 Shares of Abbott Laboratories $ABT - MarketBeat
Focus Partners Wealth Has $71 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Fred Alger Management LLC Has $20.29 Million Position in Abbott Laboratories $ABT - MarketBeat
Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness and Modest Undervaluation Estimate - simplywall.st
Abbott Diabetes And Cardiology Updates Test Growth Story For Investors - Yahoo Finance
Abbott (ABT) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Retired Abbott Labs GC Made Almost $6.6M In Half A Year - Law360
Jain Global LLC Increases Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Biotechnology Market Is Booming So Rapidly | Abbott Laboratories, Amgen Inc., GlaxoSmithKline - openPR.com
Hilltop Holdings Inc. Acquires 83,190 Shares of Abbott Laboratories $ABT - MarketBeat
CSM Advisors LLC Sells 65,130 Shares of Abbott Laboratories $ABT - MarketBeat
Cinctive Capital Management LP Raises Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stake Increased by Banco Bilbao Vizcaya Argentaria S.A. - MarketBeat
Abbott Laboratories $ABT Shares Bought by Bank of Nova Scotia - MarketBeat
Abbott Laboratories' Medical Devices segment revenue from 2020 to 2025, by category - Statista
Abbott Laboratories Stock (ISIN: US0028241000) Holds Steady Amid Moderate Buy Consensus and FY2026 G - AD HOC NEWS
Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India - Insider Monkey
Cannell & Spears LLC Grows Stake in Abbott Laboratories $ABT - MarketBeat
Chevy Chase Trust Holdings LLC Has $123.03 Million Stake in Abbott Laboratories $ABT - MarketBeat
Clark Capital Management Group Inc. Has $61.41 Million Stake in Abbott Laboratories $ABT - MarketBeat
California Public Employees Retirement System Lowers Stake in Abbott Laboratories $ABT - MarketBeat
Beck Mack & Oliver LLC Has $115.75 Million Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Purchased by Ameriprise Financial Inc. - MarketBeat
Abbott Laboratories $ABT Holdings Boosted by Alliancebernstein L.P. - MarketBeat
Abbott Laboratories (NYSE:ABT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
44 Wealth Management LLC Acquires 14,684 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Stock Shows Promising Developments - AD HOC NEWS
Why RMD Could Outperform Abbott Laboratories Stock - Trefis
Abbott Laboratories $ABT Stock Holdings Cut by Wellington Management Group LLP - MarketBeat
M&T Bank Corp Sells 32,804 Shares of Abbott Laboratories $ABT - MarketBeat
Sirios Capital Management L P Buys 33,302 Shares of Abbott Laboratories $ABT - MarketBeat
애보트 래버러토리스 (ABT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.75%
0.19%
자본화:
|
볼륨(24시간):